Researchers have shown that a new nuclear medicine procedure (using 68Ga-OPS202) could safely and more effectively detect cancerous gastrointestinal and pancreatic neuroendocrine tumors than current methods. The study is featured in the June issue of The Journal of Nuclear Medicine. {read more here}